Counter-UAS Funding: A Quarter-by-Quarter Analysis

All funding deals in the counter-UAS market over the last years

Below is the table listing all the deals. You can find our methodology at the end of this page.

If you want a deeper understanding of the market and its current dynamics, get our report covering the Counter-UAS Market.

Is Counter-UAS funding actually growing right now?

Counter-UAS funding is clearly bigger than it was in mid-2025, although the quarterly path is far too uneven to call it a steady acceleration.

We recorded roughly $31 million in Q2 2025, $24.5 million in Q3, more than approximately $574.5 million in Q4, about $123.9 million in Q1 2026 and more than approximately $254.7 million in Q2. Deal count tells a different story: it stayed stuck at four for four consecutive quarters before rising to six in Q2 2026.

The more useful change is happening inside those totals. Q2 and Q3 2025 were mostly a market for sub-$20 million Seed rounds. From Q4 onward, companies started raising $20 million, $35 million, $50 million and eventually $200 million rounds as well.

So Counter-UAS funding today has a much higher ceiling than it did a year earlier, even though total dollars still jump around wildly from quarter to quarter.

Quarter	Deals	Capital	Median round	Largest round
Q2 2025	4	$31.0M	$6.2M	$17.0M
Q3 2025	4	$24.5M	$5.8M	$10.0M
Q4 2025	4	>≈$574.5M	$31.5M	$510.0M
Q1 2026	4	≈$123.9M	$35.3M	≈$52.5M
Q2 2026	6	>≈$254.7M	$13.5M	$200.0M

When did Counter-UAS funding really change?

The Counter-UAS funding market really changed in Q4 2025, when the median round jumped from $5.8 million to $31.5 million and three of the four deals moved beyond Seed.

Q3 had been almost entirely an early-stage market. All four financings were Seed, no company raised more than $10 million, and three rounds sat between $5 million and $20 million.

One quarter later, the mix looked completely different. MatrixSpace raised $20 million in Series B financing, Beijing Lizheng disclosed a Series C above roughly $42.9 million, and CHAOS Industries raised $510 million. Thermopylae Aerospace was the only small Seed financing left in the quarter.

The median is useful here because CHAOS does not explain everything. A jump from $5.8 million to $31.5 million means the middle of the quarter changed too. Q4 was when Counter-UAS financing first started looking like a market that could support serious scale-up rounds.

Was Q4 2025 Counter-UAS funding basically just the CHAOS Industries round?

Yes. CHAOS Industries explains most of Q4 2025's spectacular Counter-UAS funding headline, although the rest of the quarter was still materially stronger than Q3.

CHAOS raised $510 million and absorbed 88.8% of all capital that quarter. The company said the financing would support expanded product development and manufacturing, so one unusually large growth round pushed the quarterly total above $574 million.

Removing every round above $50 million gives us a much cleaner comparison. Counter-UAS funding still rose from $24.5 million in Q3 to more than approximately $64.5 million in Q4. Beijing Lizheng and MatrixSpace were therefore part of a broader move toward bigger checks.

There were two things happening at once: an extreme outlier at the top and a genuine increase in financing size underneath it. Looking only at the $574 million headline would exaggerate the first and miss the second.

Did Counter-UAS funding actually get stronger in Q1 2026 after the headline total fell?

Yes. Q1 2026 was probably the cleanest Counter-UAS funding quarter in the period, with three separate companies raising roughly $35 million to $53 million rather than one company swallowing almost the whole market.

Total capital fell sharply from Q4 because the previous quarter's giant round disappeared. Once we exclude financings above $50 million, however, funding actually increased from more than approximately $64.5 million to roughly $71.4 million.

The deals were unusually well distributed. TYTAN Technologies and Frankenburg Technologies each raised approximately $35.3 million Series A rounds, while Sensofusion raised about $52.5 million in Series B financing. Shotling added a much smaller early-stage round.

This was the strongest middle of the market we found. Three meaningful scale-up financings landed in the same quarter without needing a single $100 million-plus deal to make the numbers look good.

Was Q2 2026 genuinely stronger for Counter-UAS funding, or was it mostly Allen Control Systems?

Q2 2026 genuinely broadened the Counter-UAS market in deal count, while Allen Control Systems still accounted for nearly four-fifths of the money.

Six companies raised capital, up from four in Q1, and three of those six were first financings. That is the broadest quarter in our five-quarter dataset.

The dollars tell a less flattering story. Allen's $200 million Series B represented 78.5% of quarterly capital. Once rounds above $50 million are removed, underlying funding drops about 23% from Q1.

The median fell from $35.3 million to $13.5 million at the same time. More startups were getting financed, but several newcomers were raising small rounds while one established company pulled the total sharply upward.

Q2 was therefore an expansion in the number of funded companies, with capital still heavily concentrated around the biggest scale-up.

Are more new Counter-UAS startups getting funded now?

New Counter-UAS startup funding clearly came back in Q2 2026, when first financings reached half of all deals.

The progression had been rough before that. First financings represented 50% of Q2 2025 deals, fell to 25% in Q3 and disappeared among the classified Q4 transactions. They recovered to 25% in Q1 2026 and then reached 50% again in Q2.

Molfar Defence Technologies, Valkyr Defense Systems and Esh-Tech Systems were the new names in the latest quarter. Their presence matters more for market breadth than for capital: together, first financings captured only about 8% of Q2 funding.

New company formation is recovering faster than the money going into those new companies. Investors are funding fresh Counter-UAS teams again, while the large checks remain reserved for businesses further along the development curve.

Our first-financing classification is directional because it relies on public financing histories rather than a perfect reconstruction of every historical transaction.

Is Counter-UAS capital increasingly going to companies that have already raised before?

Yes. Follow-on Counter-UAS companies currently take most of the capital even as new startups return to the market.

The split becomes obvious from Q3 2025 onward. Follow-on companies captured the large majority of quarterly dollars, reaching roughly 92% of capital in Q2 2026.

Round size explains much of the gap. The median first financing in Q2 was approximately $2.3 million, compared with $25 million for follow-ons. Molfar was raising its first outside round for tactical radar development, while Fortem Technologies was already raising a Series B tranche alongside Lockheed Martin and Allen was financing manufacturing and deployment at a completely different scale.

Getting into the Counter-UAS funding market and getting a very large round are increasingly two separate milestones.

Are Counter-UAS investors writing much bigger checks now?

Counter-UAS round sizes have moved up dramatically from mid-2025, with repeated $35 million to $50 million financings and a $200 million Series B appearing after a period dominated by much smaller Seed rounds.

In Q2 and Q3 2025, the largest transactions were TYTAN's roughly $17 million financing and Aurelius Systems' $10 million Seed round. The next three quarters produced several financings that would have been enormous compared with anything in those earlier quarters.

The use of funds changed too. CHAOS talked about manufacturing. TYTAN raised to expand production across Germany, Ukraine and allied markets. Frankenburg raised to build missile manufacturing capacity. Allen raised to scale Bullfrog manufacturing and deployment.

The larger rounds are not just a valuation story. Companies receiving them are increasingly asking investors to finance factories, supply chains, deployment and production capacity.

Quarter	Company	Stage	Round
Q2 2025	TYTAN Technologies	Seed	≈$17.0M
Q3 2025	Aurelius Systems	Seed	$10.0M
Q4 2025	MatrixSpace	Series B	$20.0M
Q4 2025	Beijing Lizheng	Series C	>≈$42.9M
Q1 2026	TYTAN Technologies	Series A	$35.3M
Q1 2026	Frankenburg Technologies	Series A	$35.3M
Q1 2026	Sensofusion	Series B	≈$52.5M
Q2 2026	Fortem Technologies	Series B	$25.0M
Q2 2026	Allen Control Systems	Series B	$200.0M

Is Counter-UAS becoming a later-stage funding market?

Only partly. Counter-UAS funding currently looks split between young Seed companies and a smaller group of businesses raising much larger scale-up rounds.

Q4 initially looked like a clean move toward maturity because 75% of the quarter's deals were Series B or later. Q1 then moved back toward Series A, and Seed deals returned to 66.7% of transaction volume in Q2.

Company age moves in the same direction. Median company age rose from around 1.5 years in mid-2025 to 4.5 years in Q4, then came back to 2.5 years in both 2026 quarters. Within Q2, companies receiving first financings had a median age of only one year, compared with four years for follow-on companies.

We are increasingly seeing two groups side by side: very young startups can still get into the market, while companies with several years of technical and commercial progress can now tap much deeper pools of capital.

Quarter	Seed	Series A	Series B	Series C/D+
Q2 2025	75%	0%	0%	0%
Q3 2025	100%	0%	0%	0%
Q4 2025	25%	0%	25%	50%
Q1 2026	25%	50%	25%	0%
Q2 2026	66.7%	0%	33.3%	0%

Which Counter-UAS category is actually gaining the most momentum?

Kinetic-defeat Counter-UAS companies have the strongest multi-quarter momentum today because they keep producing both new deals and larger follow-on financings.

The category appears in every quarter. TYTAN and Thor Dynamics were present in Q2 2025, Nordic Air Defence and Perseus Defense in Q3, Thermopylae in Q4, then TYTAN, Frankenburg and Shotling in Q1. Allen Control Systems and Askari Defense continued the run in Q2.

Capital share is much less stable than deal activity. Kinetic defeat reached 82% of Q2 funding because Allen was so large, so that percentage exaggerates how dominant the category really is.

The steadier evidence is the number and variety of companies getting funded. We see cheap interceptors, robotic gun systems, guided missiles and close-range hard-kill systems attracting money across several quarters. Integration is also remarkably persistent, appearing in every quarter, but kinetic defeat has produced more funded companies overall.

Did Counter-UAS sensors really take over the market?

No. The apparent Counter-UAS sensor boom was mainly a Q4 2025 spike and faded immediately afterward.

Sensors captured more than 90% of Q4 capital because CHAOS and MatrixSpace happened to raise in the same quarter. There were no sensor financings in Q1 2026, and the category returned in Q2 with Molfar's approximately $2.3 million round.

That pattern looks very different from kinetic defeat or integration, where companies keep appearing quarter after quarter.

Q4 did show that investors are willing to put very large sums into a sensor company once it reaches the right level of maturity. It did not produce sustained evidence that capital across the Counter-UAS market was rotating toward sensors.

Why are kinetic-defeat Counter-UAS companies getting more funding now?

Kinetic-defeat Counter-UAS companies are attracting larger rounds because more of them are now raising money to manufacture and deploy systems at scale.

TYTAN's Series A was designed to expand its manufacturing footprint across Germany, Ukraine and allied markets. Frankenburg raised to build missile production capacity, and its Mark I interceptor had already moved from development into live-fire validation. Allen's financing similarly centered on manufacturing and accelerating Bullfrog deployments.

The demand backdrop has also become much stronger. NATO's 2025 capability targets increased the emphasis on air and missile defence, while the Hague defence commitment called for higher defence investment and stronger industrial capacity across the Alliance. NATO says European Allies and Canada increased defence spending by nearly 20% in real terms during 2025.

The economics of the threat are pushing investors in the same direction. Militaries need ways to defeat large numbers of relatively cheap drones without spending expensive conventional missiles on every target. Companies that can plausibly manufacture affordable interceptors or other hard-kill systems in volume have a much clearer commercial story today than they did a few years ago.

We cannot tie any individual funding round directly to a NATO decision, but the procurement and industrial environment around these companies has clearly become more supportive.

Why did Europe suddenly dominate Counter-UAS funding in Q1 2026?

European Counter-UAS funding dominated Q1 2026 because three large scale-up rounds landed at almost the same time: Sensofusion, TYTAN Technologies and Frankenburg Technologies.

All four transactions that quarter involved European companies. Sensofusion raised approximately $52.5 million, while TYTAN and Frankenburg each raised about $35.3 million. Denmark's Shotling added a much smaller early-stage financing.

The timing lines up with a broader European push toward defence production. TYTAN's investors included the NATO Innovation Fund, and its round was tied to manufacturing expansion. DEUTZ also took a strategic stake while agreeing to help industrialize energy and propulsion systems. Frankenburg was building out missile production and partnerships across Europe.

The European Commission later selected €1.07 billion of investment across 57 European Defence Fund projects, including drones and counter-drone systems and projects supporting the European Drone Defence Initiative.

Europe did not hold that quarterly dominance. North America returned to roughly half of the deals and about 92% of capital in Q2, largely because the biggest American rounds were much larger. Europe has proved it can produce a very strong Counter-UAS funding quarter, while North America continues to generate the largest individual private financings.

Are strategic investors becoming more important in Counter-UAS funding?

Yes. Strategic investors in Counter-UAS appeared in four consecutive quarters, and their role is becoming increasingly tied to production, integration and deployment.

We found no strategic-backed financing in Q2 2025. EOTECH appeared alongside Aurelius in Q3, L3Harris invested in MatrixSpace in Q4, DEUTZ joined TYTAN in Q1, and Q2 brought Lockheed Martin into Fortem plus FFG into Esh-Tech.

The relationships go well beyond putting a corporate name on the cap table. L3Harris had already integrated its UAS TRACER software with MatrixSpace radar. DEUTZ agreed to work with TYTAN on drive, battery and industrialization systems. Lockheed Martin's $25 million Fortem investment was explicitly tied to scaled production and deployment within its Sanctum Counter-UAS ecosystem.

That helps explain why corporate investors are showing up now. Counter-UAS startups increasingly need manufacturing capacity, platform integration, government-market access and established defence supply chains. A strategic investor can bring those pieces alongside the capital.

Quarter	Strategic-backed deals	Share	Example
Q2 2025	0	0%	None
Q3 2025	1	25%	EOTECH / Aurelius
Q4 2025	1	25%	L3Harris / MatrixSpace
Q1 2026	1	25%	DEUTZ / TYTAN
Q2 2026	2	33.3%	Lockheed Martin / Fortem; FFG / Esh-Tech

Are the same VC firms leading every Counter-UAS round?

No. Counter-UAS lead investors are surprisingly dispersed across the five quarters, with no disclosed lead repeating across the selected financings.

The names range from generalist venture investors and growth funds to defence specialists and the NATO Innovation Fund. We do not see one or two firms repeatedly appearing as the lead behind the market's largest rounds.

Disclosure is the main limitation. Only half of Q2 2025 deals had a disclosed lead, versus full coverage in Q4 and 66.7% in Q2 2026. An undisclosed investor could therefore change the picture.

Based on what is publicly visible today, the investor pool looks broader rather than more concentrated. The concentration problem in Counter-UAS funding is much clearer at the company level than at the lead-investor level.

What is the Counter-UAS funding market still missing?

The Counter-UAS funding market still lacks a dependable middle layer between small Seed rounds and the biggest scale-up winners.

Q1 2026 briefly solved that problem. Three of four financings landed between roughly $35 million and $53 million, giving the quarter real depth.

Q2 moved back toward a barbell. We recorded several small financings, Fortem at $25 million and then a huge gap before the quarter's largest deal. The $20 million-to-$100 million range became much thinner again.

A healthier middle would mean seeing multiple companies raise Series A and B rounds in roughly the $20 million-to-$75 million range quarter after quarter, across several Counter-UAS categories. We have seen that happen once. We have not seen it become routine yet.

Does the latest evidence still support the same Counter-UAS funding trend?

The latest Counter-UAS funding announcements still support the same broad picture: fresh companies are entering while more developed startups are raising larger amounts to industrialize their products.

Our main dataset stops at June 30, 2026 so every quarter can be compared on a complete basis. We separately checked what happened after that cutoff rather than mixing later deals into the quarterly calculations.

Aurelius Systems subsequently announced a $40 million Series A to expand production and vertically integrate parts of its laser supply chain. More recently, Germany's Ground A disclosed a €9.1 million pre-Seed round for its laser-based GA 1000, with the company already talking about industrialization and series production.

Those announcements sit at opposite ends of the financing curve. One is a larger follow-on round tied to production readiness; the other is a substantial first institutional round for a company founded only recently.

The pattern we identified through Q2 has not obviously broken since the cutoff. Counter-UAS funding still supports both new entrants and a smaller group moving aggressively toward manufacturing.

What is the Counter-UAS funding trend actually telling us?

Counter-UAS funding has become much larger, but the growth comes in bursts. Quarterly totals remain highly sensitive to individual companies, which makes raw funding charts unusually easy to misread.

The most durable change is round size. Mid-2025 was overwhelmingly a small Seed market; by 2026, companies with enough product and customer traction could raise tens or hundreds of millions of dollars.

Breadth improved later than round size. Deal count only really moved in Q2 2026, when six companies raised and first financings returned to half of all transactions. The money is still flowing much faster toward established companies than toward those newcomers.

Kinetic defeat currently has the broadest category momentum, with funded companies appearing quarter after quarter. Integration has also been remarkably consistent. Sensors have produced some major financings, but their quarterly dominance has so far been temporary.

The maturity story is increasingly split. Very young companies continue to get Seed funding while another group is already financing factories, supply chains, integrations and deployment. The $20 million-to-$75 million middle still needs to become more consistent.

Strategic capital is also becoming harder to ignore. EOTECH, L3Harris, DEUTZ, Lockheed Martin and FFG appeared across four consecutive quarters, often alongside a direct industrial or integration relationship with the startup they backed.

The market is moving from startup experimentation toward industrial scale while still creating new companies underneath. The progress is real, but the quarterly funding totals remain a noisy way to measure it.